12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant price movements during Friday's intraday session. Notable gainers included Aravive, Lipella Pharmaceuticals, Sagimet Biosciences, Catalyst Biosciences, Redhill Biopharma, and Eiger BioPharmaceuticals. On the other hand, Processa Pharma, Atreca, RVL Pharmaceuticals, Adial Pharmaceuticals, Renovaro Biosciences, and Outlook Therapeutics saw their stock prices decline.
October 20, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Atreca's stock declined by 25.7% to $0.27, with a trading volume of 2.3 million shares.
The substantial drop in Atreca's stock price, along with a high trading volume, suggests strong selling pressure, which could drive further price declines in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Processa Pharma's stock fell 32.4% to $0.36 during Friday's session, with a trading volume of 2.8 million shares.
The significant drop in Processa Pharma's stock price, along with a high trading volume, indicates strong selling pressure, which could lead to further price declines in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Aravive's stock rose 67.5% to $0.24 during Friday's session, with a trading volume of 90.0 million shares.
The significant increase in Aravive's stock price, coupled with a high trading volume, indicates strong investor interest and could lead to continued upward momentum in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Lipella Pharmaceuticals' stock moved upwards by 42.27% to $2.29, with a trading volume of 39.3 million shares.
The substantial rise in Lipella Pharmaceuticals' stock price, along with a high trading volume, suggests strong investor interest, which could drive further price increases in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100